Cargando…
Understanding the Tumor Immune Microenvironment in Renal Cell Carcinoma
SIMPLE SUMMARY: Over the last decade there has been a significant increase in the number of therapies that activate the host’s immune system to target and eliminate renal cell carcinoma (RCC) tumors. The superior efficacy of these agents demonstrates that host control of RCC requires a robust and ef...
Autores principales: | Shapiro, Daniel D., Dolan, Brendan, Laklouk, Israa A., Rassi, Sahar, Lozar, Taja, Emamekhoo, Hamid, Wentland, Andrew L., Lubner, Meghan G., Abel, Edwin Jason |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177515/ https://www.ncbi.nlm.nih.gov/pubmed/37173966 http://dx.doi.org/10.3390/cancers15092500 |
Ejemplares similares
-
A case of metastatic renal cell carcinoma with concomitant Castleman's disease treated with immunotherapy
por: Lozar, Taja, et al.
Publicado: (2021) -
Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and Beyond
por: Lozar, Taja, et al.
Publicado: (2023) -
The Biology and Clinical Potential of Circulating Tumor Cells
por: Lozar, Taja, et al.
Publicado: (2019) -
Understanding the Role of Innate Immune Cells and Identifying Genes in Breast Cancer Microenvironment
por: Shihab, Israa, et al.
Publicado: (2020) -
Cervical Cancer Screening Postpandemic: Self-Sampling Opportunities to Accelerate the Elimination of Cervical Cancer
por: Lozar, Taja, et al.
Publicado: (2021)